Oncotarget

Research Papers:

Cyr61 as mediator of Src signaling in triple negative breast cancer cells

María Pilar Sánchez-Bailón _, Annarica Calcabrini, Víctor Mayoral-Varo, Agnese Molinari, Kay-Uwe Wagner, Jesús Pérez Losada, Sergio Ciordia, Juan Pablo Albar and Jorge Martín-Pérez

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2015; 6:13520-13538. https://doi.org/10.18632/oncotarget.3760

Metrics: PDF 1167 views  |   HTML 1480 views  |   ?  


Abstract

María Pilar Sánchez-Bailón1,*, Annarica Calcabrini1,2,*, Víctor Mayoral-Varo1,*, Agnese Molinari2, Kay-Uwe Wagner3, Jesús Pérez Losada4, Sergio Ciordia5, Juan Pablo Albar5,#, Jorge Martín-Pérez1

1Departamento de Biología del Cáncer, Instituto de Investigaciones Biomédicas A. Sols (CSIC/UAM), Madrid 28029, Spain

2Dipartimento Tecnologie e Salute, Istituto Superiore di Sanità, Roma 00161, Italy

3Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198-6805, USA

4Centro de Investigación del Cáncer (CSIC/USAL), Campus Unamuno, Salamanca 37007, Spain

5Servicio de Proteómica, Centro Nacional de Biotecnología (CSIC), Madrid 28049, Spain

*These authors have contributed equally to this work

#This manuscript is dedicated to Juan Pablo Albar who passed away the 19th of July 2014

Correspondence to:

Jorge Martín-Pérez, e-mail: jmartin@iib.uam.es

Keywords: c-Src, Cyr61, triple negative breast cancer, migration, invasion

Received: December 30, 2014     Accepted: April 08, 2015     Published: April 20, 2015

ABSTRACT

SFKs are involved in tumorigenesis and metastasis. Here we analyzed c-Src contribution to initial steps of metastasis by tetracycline-dependent expression of a specific shRNA-c-Src, which suppressed c-Src mRNA and protein levels in metastatic MDA-MB-231 cells. c-Src suppression did not alter cell proliferation or survival, but it significantly reduced anchorage-independent growth. Concomitantly with diminished tyrosine-phosphorylation/activation of Fak, caveolin-1, paxillin and p130CAS, c-Src depletion also inhibited cellular migration, invasion and transendothelial migration. Quantitative proteomic analyses of the secretome showed that Cyr61 levels, which were detected in the exosomal fraction, were diminished upon shRNA-c-Src expression. In contrast, Cyr61 expression was unaltered inside cells. Cyr61 partially colocalized with cis-Golgi gp74 marker and with exosomal marker CD63, but c-Src depletion did not alter their cellular distribution. In SUM159PT cells, transient c-Src suppression also reduced secreted exosomal Cyr61 levels. Furthermore, conditional expression of a c-Src dominant negative mutant (SrcDN, c-Src-K295M/Y527F) in MDA-MB-231 and in SUM159PT diminished secreted Cyr61 as well. Cyr61 transient suppression in MDA-MB-231 inhibited invasion and transendothelial migration. Finally, in both MDA-MB-231 and SUM159PT, a neutralizing Cyr61 antibody restrained migration. Collectively, these results suggest that c-Src regulates secreted proteins, including the exosomal Cyr61, which are involved in modulating the metastatic potential of triple negative breast cancer cells.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 3760